chr5-141574081-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_005219.5(DIAPH1):c.1769G>A(p.Gly590Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,612,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G590V) has been classified as Likely benign.
Frequency
Consequence
NM_005219.5 missense
Scores
Clinical Significance
Conservation
Publications
- DIAPH1-related sensorineural hearing loss-thrombocytopenia syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- autosomal dominant nonsyndromic hearing loss 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
- progressive microcephaly-seizures-cortical blindness-developmental delay syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DIAPH1 | ENST00000389054.8 | c.1769G>A | p.Gly590Asp | missense_variant | Exon 16 of 28 | 5 | NM_005219.5 | ENSP00000373706.4 | ||
| DIAPH1 | ENST00000518047.5 | c.1742G>A | p.Gly581Asp | missense_variant | Exon 15 of 27 | 5 | ENSP00000428268.2 | |||
| DIAPH1 | ENST00000647433.1 | c.1769G>A | p.Gly590Asp | missense_variant | Exon 16 of 29 | ENSP00000494675.1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151414Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000445 AC: 11AN: 247096 AF XY: 0.0000522 show subpopulations
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1460608Hom.: 0 Cov.: 36 AF XY: 0.00000964 AC XY: 7AN XY: 726458 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151532Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74022 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Autosomal dominant nonsyndromic hearing loss 1;C5567650:Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome Uncertain:1
This sequence change replaces glycine with aspartic acid at codon 590 of the DIAPH1 protein (p.Gly590Asp). The glycine residue is weakly conserved and there is a moderate physicochemical difference between glycine and aspartic acid. This variant is present in population databases (rs189809247, ExAC 0.07%). This variant has not been reported in the literature in individuals with DIAPH1-related conditions. ClinVar contains an entry for this variant (Variation ID: 289391). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at